STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy

Chemoradiotherapy (CRT) represents a standard treatment for many human cancers, frequently combined with radical surgical resection. However, a considerable percentage of primary cancers are at least partially resistant to CRT, which represents a substantial clinical problem, because it exposes canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Spitzner, Melanie, Ebner, Reinhard, Wolff, Hendrik A., Ghadimi, B. Michael, Wienands, Jürgen, Grade, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276953/
https://www.ncbi.nlm.nih.gov/pubmed/25268165
http://dx.doi.org/10.3390/cancers6041986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276953/
https://www.ncbi.nlm.nih.gov/pubmed/25268165
http://dx.doi.org/10.3390/cancers6041986

Ejemplares similares